Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 9;71(49):1550-1554.
doi: 10.15585/mmwr.mm7149a3.

Chronic Obstructive Pulmonary Disease Mortality by Industry and Occupation - United States, 2020

Affiliations

Chronic Obstructive Pulmonary Disease Mortality by Industry and Occupation - United States, 2020

Girija Syamlal et al. MMWR Morb Mortal Wkly Rep. .

Abstract

Chronic obstructive pulmonary disease (COPD), a progressive lung disease, is characterized by long-term respiratory symptoms and airflow limitation (1). COPD accounts for most of the deaths from chronic lower respiratory diseases, the sixth leading cause of death in the United States in 2020.* Workplace exposures and tobacco smoking are risk factors for COPD; however, one in four workers with COPD have never smoked (2-4). To describe COPD mortality among U.S. residents aged ≥15 years categorized as ever-employed (i.e., with information on their usual industry and occupation), CDC analyzed the most recent 2020 multiple cause-of-death data from 46 states and New York City.§ Among 3,077,127 decedents, 316,023 (10.3%) had COPD listed on the death certificate. The highest age-adjusted** COPD death rates per 100,000 ever-employed persons were for females (101.3), White persons (116.9), and non-Hispanic or Latino (non-Hispanic) persons (115.8). The highest proportionate mortality ratios (PMRs)†† were for workers employed in the mining industry (1.3) and in food preparation and serving related occupations (1.3). Elevated COPD mortality among workers in certain industries and occupations underscores the importance of targeted interventions (e.g., reduction or elimination of COPD-associated risk factors, engineering controls, and workplace smoke-free policies) to prevent COPD from developing and to intervene before illness becomes symptomatic or severe.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

References

    1. Yawn BP, Mintz ML, Doherty DE. GOLD in practice: chronic obstructive pulmonary disease treatment and management in the primary care setting. Int J Chron Obstruct Pulmon Dis 2021;16:289–99. 10.2147/COPD.S222664 - DOI - PMC - PubMed
    1. Blanc PD, Annesi-Maesano I, Balmes JR, et al. The occupational burden of non-malignant respiratory diseases. An official American Thoracic Society and European Respiratory Society statement. Am J Respir Crit Care Med 2019;199:1312–34. 10.1164/rccm.201904-0717ST - DOI - PMC - PubMed
    1. Syamlal G, Doney B, Hendricks S, Mazurek JM. Chronic obstructive pulmonary disease and U.S. workers: prevalence, trends, and attributable cases associated with work. Am J Prev Med 2021;61:e127–37. 10.1016/j.amepre.2021.04.011 - DOI - PMC - PubMed
    1. Syamlal G, Doney B, Mazurek JM. Chronic obstructive pulmonary disease prevalence among adults who have never smoked, by industry and occupation—United States, 2013–2017. MMWR Morb Mortal Wkly Rep 2019;68:303–7. 10.15585/mmwr.mm6813a2 - DOI - PMC - PubMed
    1. Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance—United States, 1999–2011. Chest 2013;144:284–305. 10.1378/chest.13-0809 - DOI - PMC - PubMed